UH
ABBV icon

Unigestion Holding’s AbbVie ABBV Stock Holding History

Unigestion Holding’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$5.18M Sell
24,740
-30,983
-56% -$6.02M 0.3% 75
2024
Q4 		$9.9M Sell
55,723
-23,804
-30% -$4.38M 0.57% 57
2024
Q3 		$15.7M Sell
79,527
-25,150
-24% -$4.69M 0.76% 52
2024
Q2 		$16.2M Sell
104,677
-8,901
-8% -$1.47M 0.89% 46
2024
Q1 		$20.7M Buy
113,578
+8,901
+9% +$1.53M 1.01% 42
2023
Q4 		$16.2M Sell
104,677
-70,023
-40% -$10.2M 0.89% 46
2023
Q3 		$26M Sell
174,700
-10,499
-6% -$1.54M 1.6% 23
2023
Q2 		$24.7M Sell
185,199
-79,796
-30% -$11.7M 1.43% 27
2023
Q1 		$41.8M Sell
264,995
-15,599
-6% -$2.38M 2.27% 11
2022
Q4 		$45.6M Buy
280,594
+22,101
+9% +$3.39M 2.42% 12
2022
Q3 		$36.9M Buy
258,493
+51,085
+25% +$7.33M 2.14% 14
2022
Q2 		$31.8M Buy
207,408
+13,790
+7% +$2.11M 1.78% 21
2022
Q1 		$31.4M Buy
193,618
+34,895
+22% +$5.07M 1.34% 27
2021
Q4 		$21.5M Buy
158,723
+73,850
+87% +$8.72M 0.87% 37
2021
Q3 		$9.15M Sell
84,873
-8,226
-9% -$940K 0.37% 52
2021
Q2 		$10.5M Buy
93,099
+38,135
+69% +$4.29M 0.38% 57
2021
Q1 		$5.95M Buy
54,964
+42,527
+342% +$4.55M 0.21% 68
2020
Q4 		$1.33M Sell
12,437
-24,775
-67% -$2.38M 0.05% 122
2020
Q3 		$3.26M Buy
+37,212
New +$3.5M 0.11% 74
2019
Q3 		– Sell
-25,187
Closed -$1.83M – 224
2019
Q2 		$1.83M Hold
25,187
– – 0.05% 153
2019
Q1 		$2.03M Sell
25,187
-35,571
-59% -$2.91M 0.05% 152
2018
Q4 		$5.6M Hold
60,758
– – 0.14% 113
2018
Q3 		$5.75M Sell
60,758
-26,902
-31% -$2.55M 0.12% 138
2018
Q2 		$8.12M Buy
+87,660
New +$8.56M 0.16% 127

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Unigestion Holding's ABBV Position: Q1 2025 in Review

Unigestion Holding reduced its AbbVie (ABBV) stake by 56% in Q1 2025, selling an estimated $6.02M and leaving 24,740 shares worth $5.18M. The position accounts for 0.3% of the portfolio, ranked #75.

Unigestion Holding first reported a position in ABBV in Q2 2018 and has held it in 24 quarters since. The position peaked at $45.6M in Q4 2022. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Unigestion Holding held 24,740 shares of AbbVie worth $5.18M as of Q1 2025.
  • Unigestion Holding sold 30,983 AbbVie shares in Q1 2025, an estimated $6.02M.
  • AbbVie made up 0.3% of Unigestion Holding's portfolio in Q1 2025, its #75 holding.
  • Unigestion Holding first reported a position in AbbVie in Q2 2018 and has held it in 24 quarters since.
  • Unigestion Holding's AbbVie position peaked at $45.6M in Q4 2022.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Unigestion Holding's 13F filing for Q1 2025, filed 10 Apr 2025.